{"denoms":[{"counts":[{"groupId":"BG000","value":"46"}],"units":"Participants"}],"groups":[{"description":"Bevacizumab 15 mg/kg IV, every 3 weeks (one cycle) until disease progression or adverse effects prohibit further therapy","id":"BG000","title":"Bevacizumab"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.3","value":"46.4"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"20-29 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"30-39 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}]}],"title":"40-49 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"50-59 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"60-69 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"46"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"45"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Canada"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Adenosquamous"},{"categories":[{"measurements":[{"groupId":"BG000","value":"43"}]}],"title":"Squamous Cell Carcinoma"}],"paramType":"NUMBER","title":"Histologic Type","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Unspecified"},{"categories":[{"measurements":[{"groupId":"BG000","value":"45"}]}],"title":"Recurrent/Persistent"}],"paramType":"NUMBER","title":"International Federation of Gynecology and Obstetrics (FIGO) Stage","unitOfMeasure":"participants"}],"populationDescription":"Eligible and treated patients."}